Last reviewed · How we verify
ramipril, candesartan
ramipril, candesartan is a Small molecule drug developed by Gachon University Gil Medical Center. It is currently FDA-approved.
At a glance
| Generic name | ramipril, candesartan |
|---|---|
| Sponsor | Gachon University Gil Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The COVID-RASi Trial (COVID-19) (PHASE3)
- Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study
- Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction (PHASE4)
- Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
- Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia (PHASE3)
- Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography (NA)
- NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ramipril, candesartan CI brief — competitive landscape report
- ramipril, candesartan updates RSS · CI watch RSS
- Gachon University Gil Medical Center portfolio CI
Frequently asked questions about ramipril, candesartan
What is ramipril, candesartan?
ramipril, candesartan is a Small molecule drug developed by Gachon University Gil Medical Center.
Who makes ramipril, candesartan?
ramipril, candesartan is developed and marketed by Gachon University Gil Medical Center (see full Gachon University Gil Medical Center pipeline at /company/gachon-university-gil-medical-center).
What development phase is ramipril, candesartan in?
ramipril, candesartan is FDA-approved (marketed).
Related
- Manufacturer: Gachon University Gil Medical Center — full pipeline
- Compare: ramipril, candesartan vs similar drugs
- Pricing: ramipril, candesartan cost, discount & access